Brief: Aura Biosciences Announces Publication Of Preclinical Data
27/05/2022 24:40
May 26 (Reuters) - Aura Biosciences Inc AURA.O :
* AURA BIOSCIENCES ANNOUNCES PUBLICATION OF PRECLINICAL DATA
OF
THE COMBINATION OF VDCS WITH IMMUNE CHECKPOINT INHIBITORS AT THE
2022 ASCO ANNUAL MEETING
Source text for Eikon: ID:nBw6MlJdHa
Further company coverage: AURA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aura Biosciences
See all newsBrief: Aura Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Aura Biosciences - May Offer Securities Up To $500 Million Aggregate
Brief: Aura Biosciences Reports Second Quarter 2026 Financial Results And Recent Business Highlights
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Aura Biosciences Q1 net loss widens on higher R&D costs